Memorial Sloan Kettering Cancer Center Hereditary Cancer Genetics Incorporation into Clinical Care 2022

Memorial Sloan Kettering Cancer Center Hereditary Cancer Genetics Incorporation into Clinical Care 2022

$20.00

+ Include: 28 videos + 25 pdfs, size: 6.22 GB

+ Target Audience: practicing medical oncologists, genetic counselors, advanced practice providers, and other health care

Description

+ Include: 28 videos + 25 pdfs, size: 6.22 GB

+ Target Audience: practicing medical oncologists, genetic counselors, advanced practice providers, and other health care

+ Sample video: contact me for sample video

+ Information:

Date & Location

Friday, September 30, 2022, 7:00 AM – 5:30 PM, Zuckerman Research Center, 417 East 68th Street, New York, NY

Specialties
Specialties – Genetics, Oncology and Hematology
Overview

This Hereditary Cancer Genetics conference is a single-day lecture and case presentation series that provides professional training in clinical cancer genetics hosted by one of the largest cancer genetics centers. The goal of the course is to provide a foundation of knowledge in cancer genetics and highlight current developments in the field of cancer genomics to inform patient care. The course will provide:

  • an overview of cancer genetics risk assessment;
  • discuss cancer-specific risks and management for hereditary cancer syndromes;
  • highlight oncologic therapeutic implications of germline findings;
  • review genetic findings from tumor-profiling results with hereditary implications; and
  • discuss the changing landscape of provision of genetics care.

Who Should Attend

The conference is intended for practicing medical oncologists, genetic counselors, advanced practice providers, and other health care providers who are interested in learning about the incorporation of genetic testing into patient care.

Objectives
  1. Identify clinical features of hereditary cancer predisposition syndromes and facilitate interpretation of genetic test results
  2. Evaluate the recommended surveillance and risk reduction interventions for patients with hereditary cancer predisposition syndromes
  3. Enhance awareness of implications of germline genetic testing on therapeutic management of patients with cancer, including oncological and surgical interventions
  4. Apply the understanding of tumor profiling results to identify patients at risk for hereditary cancer syndromes
  5. Recognize the utility of digital platforms to facilitate genetic testing

 

+ Topics:

Case Studies from Tumor Normal Sequencing.mp4

Case Studies from Tumor Normal Sequencing.pdf

Case Studies in Hereditary Breast Cancer.mp4

Case Studies in Hereditary Breast Cancer.pdf

Case Studies in Hereditary Gastrointestinal Cancers.mp4

Case Studies in Hereditary Gastrointestinal Cancers.pdf

Case Studies in Hereditary Genitourinary Cancers.mp4

Case Studies in Hereditary Genitourinary Cancers.pdf

Case Studies in Hereditary Gynecologic Cancers.mp4

Case Studies in Hereditary Gynecologic Cancers.pdf

Case Studies in Hereditary Pediatric Cancers.mp4

Case Studies in Hereditary Pediatric Cancers.pdf

Case Studies in Rare Hereditary Cancers.mp4

Case Studies in Rare Hereditary Cancers.pdf

Challenges of Consumer Genetic Testing.mp4

Challenges of Consumer Genetic Testing.pdf

Comprehensive Clinical Management of Individuals with Increased Susceptibility to Multiple Cancers.mp4

Comprehensive Clinical Management of Individuals with Increased Susceptibility to Multiple Cancers.pdf

Emerging Digitally-Enhanced Models of Genomic Service Delivery.mp4

Emerging Digitally-Enhanced Models of Genomic Service Delivery.pdf

Emerging Opportunities for Targeted Therapies in Rare Cancer Syndromes.mp4

Emerging Opportunities for Targeted Therapies in Rare Cancer Syndromes.pdf

Expanding Genetic Testing for Hereditary Genitourinary Cancers.mp4

Expanding Genetic Testing for Hereditary Genitourinary Cancers.pdf

Hereditary Pediatric Cancers.mp4

Hereditary Pediatric Cancers.pdf

Hereditary2022_Brochure.pdf

Introduction to Syndromes of Cancer Predisposition.mp4

Introduction to Syndromes of Cancer Predisposition.pdf

Longitudinal Engagement of At-Risk Individuals Through Digital Technologies.mp4

Longitudinal Engagement of At-Risk Individuals Through Digital Technologies.pdf

Management of Hereditary Breast Cancer.mp4

Management of Hereditary Breast Cancer.pdf

Managing Men with Inherited Risk for Cancer.mp4

Managing Men with Inherited Risk for Cancer.pdf

Mechanisms of Inherited Cancer Genomics.mp4

Mechanisms of Inherited Cancer Genomics.pdf

New Approaches to Facilitate Cascade Testing for Cancer Susceptibility.mp4

New Approaches to Facilitate Cascade Testing for Cancer Susceptibility.pdf

New Insights into Hereditary Hematologic Cancers.mp4

New Insights into Hereditary Hematologic Cancers.pdf

Pan-Cancer Insights from Paired Tumor Normal Sequencing.mp4

Pan-Cancer Insights from Paired Tumor Normal Sequencing.pdf

Psychosocial Considerations in the Adoption of Genomic Testing Innovations.mp4

Psychosocial Considerations in the Adoption of Genomic Testing Innovations.pdf

Question and Answer Session 2.mp4

Question and Answer Session 3.mp4

Question and Answer Session 4.mp4

Question and Answer Session.mp4

The Spectrum of Hereditary Gynecologic Cancers- Risk Management and Therapeutic Implications.mp4

The Spectrum of Hereditary Gynecologic Cancers- Risk Management and Therapeutic Implications.pdf

Updates in Hereditary Gastrointestinal Cancers.mp4

Updates in Hereditary Gastrointestinal Cancers.pdf

Reviews

There are no reviews yet.

Be the first to review “Memorial Sloan Kettering Cancer Center Hereditary Cancer Genetics Incorporation into Clinical Care 2022”

Your email address will not be published. Required fields are marked *

Related Products